期刊文献+

IL-23、IL-12在克罗恩病肠粘膜的表达及意义 被引量:3

The Expression of IL-23 and IL-12 in Intestinal Mucosa of Patients with Crohn's Disease and Its Correlation with the Disease
原文传递
导出
摘要 目的:探讨克罗恩病患者结肠粘膜组织中IL-23、IL-12的表达及其与疾病严重程度的相关性。方法:选取中南大学湘雅医院2005年4月-2011年3月经确诊的30例克罗恩病患者手术标本,对照选取30例结肠癌患者手术切除之正常结肠组织。实验设CD病变肠段组、CD正常肠段组及对照组3组。用免疫组织化学方法检测结肠内IL-12、IL-23的表达,分析IL-23、IL-12的表达与CD的疾病临床严重程度(CDAI)和内镜下肠黏膜损伤程度(CDEIS)的相关性。结果:IL-12的表达:CD病变肠段组、CD正常肠段组、对照组阳性率无统计学意义(P值>0.05)。IL-23的表达:CD病变肠段组阳性率高于CD正常肠段组,CD正常肠段组高于对照组,差异均有统计学意义(P值<0.05)。结论:IL-12在CD患者肠粘膜中不升高,而IL-23在CD表达明显升高,提示IL-23在CD粘膜免疫损伤中发挥一定作用,对CD的诊断有一定的参考价值。 ABSTRACT Objective: To investigate the expression of interleukin-12 and interleukin-23 in intestinal mucosal of patients with crohn's disease (CD) and its correlation with the disease. Methods: 30 experimental samples of CD disease were collected from the surgical patients from April 2005 to March 2011. The control samples collected from the colon cancer patients' normal colon tissue after surgery. Finally all collected samples were divided into CD diseased groups, CD normal groups and control groups. The IL-12 and IL-23 protein expression quantity was detected by using immunohistochemical techniques, and the difference among three groups in term of expression level, and evaluated the correlation between the cytokines expression levels and the Crohn's Disease activity was compared. Results: IL-23p19 positive rates in the CD diseased group were statistically significant higher than the rates in the CD normal group, and the same was true between the CD normal group and the control group, while the IL-12 positive rates among these groups were not the case. Conclusion: IL-12 didn't increase significantly in crohn's diseased intestinal mucosal while IL-23 did increase, which showed IL-23 played role in the process of crohn's disease mucosal immunity, so IL-23 could be valuable in the diagnosis of CD. Key words: Interleukin; Cytokines; Crohn's disease; Inflammatory bowel disease
出处 《现代生物医学进展》 CAS 2012年第29期5647-5650,共4页 Progress in Modern Biomedicine
关键词 白细胞介素 细胞因子 克罗恩病 炎症性肠病 Interleukin Cytokines Crohn's disease Inflammatory bowel disease
  • 相关文献

参考文献20

  • 1Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation [J]. J Clin Invest, 2006, 116:1218-1222.
  • 2Barnias G, Cominelli F. Immunopat hogenesis of inflammatory bowel disease: current concepts [J]. Cur r Opin Gast roenterol, 2007, 23: 365-369 i.
  • 3Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental path-ways for the generation of pathogenic effector TH17 and regulatory T cells[J]. Nature, 2006, 411:235-238.
  • 4Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity [J]. Lancet, 1980, 1:514.
  • 5Modigliani R, Mary JY, GETAID. Development and validation of a Crohn's disease endoscopic index: a prospective multicentric study[J]. Gut, 1989, 30:983-989.
  • 6Trinchieri, G, Pflanz, S, and Kastelein, R.A. The IL-12 family of het- erodimeric cytokines: new players in the regulation ofT cell responses [J]. Immunity, 2003, 19:641-644.
  • 7Langrish CL, Mckenzie BS, Wilson NJ, et al. IL-12 and IL-23: master regulators of innate and adaptive immunity [J]. Immunol Rev, 2004, 202:96-105.
  • 8Trinchieri G. Interleukin 12 and the regulation of innate resistance and adaptive immunity[J]. Nat Rev Immnnol, 2003, 3:133-146.
  • 9Mathur AN, Chang HC, Zisoulis DG, Kapur R, Belladonna ML, Kansas GS, Kaplan MH. T-bet is a Critical Determinant in the Insta- bility of the IL-17-Secreting T-helper Phenotype [J]. Blood, 2006, 108:1596-1601.
  • 10Fuss IJ, Becker C, Yang Zhiqiong, et al. Both IL 12p70 and IL-23 are synthesized during active crohn ' s disease and are down-regulated by treatment with anti IL-12 p40 monoclonal antibody[J]. Inflamm Bowel Dis, 2006, 12:9-15.

同被引文献65

  • 1王岭玉,田春艳,吴瑾.脱氧胆酸诱导小鼠肠上皮细胞MCP-1表达的作用及机制研究[J].军事医学,2019,43(12):897-901. 被引量:1
  • 2谭琳蓥,吴焕淦,刘慧荣,江彬,黄文燕,张必萌,施征.IGF与肠纤维化的关系及针灸的调节作用研究进展[J].上海中医药大学学报,2006,20(1):76-78. 被引量:7
  • 3肖梅,吴正祥,王巧民,张道权,叶献词.单核细胞趋化因子-1与核因子-κB在溃疡性结肠炎模型的表达[J].安徽医科大学学报,2007,42(3):289-291. 被引量:11
  • 4Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 [ J ]. Immunity, 2000, 13 ( 5 ) : 715 - 725.
  • 5Floss D M, Schroder J, Franke M, et al. Insights into IL-23 biology: From structure to function[ J]. Cytokine Growth Factor Rev, 2015, 26(5) : 569 -578.
  • 6Croxford A L, Ktdig P, Becher B. IL-12-and IL-23 in health and disease [ J ]. Cytokine Growth Factor Rev, 2014, 25 ( 4 ) : 415 -421.
  • 7Mcy M J, Cua D J. The link between IL-23 and Thl7 cell-mediated immune pathologies [ J ]. Semin Immunol, 2007, 19 ( 6 ) : 372 - 376.
  • 8Lubberts E. The IL-23-IL-17 axis in inflammatory arthritis[ J]. Nat Rev Rheumatol, 2015, 11(7) : 415 -429.
  • 9Li X, Kim K W, Cho M L, et al. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and N F-kappaB signal pathways [ J]. Immunol Lett, 2010, 127(2) : 100-107.
  • 10Suzuki E, Mellins E D, Gershwin M E, et al. The IL-23/IL-17 axis in psoriatic arthritis [ J ]. Autoimmun Rev, 2014, 13 ( 4/5 ) : 496 - 5O2.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部